Spectra Energy Corp (NYSE:SE) [Trend Analysis] moved down reacts as active mover, shares a decrease -0.75% to traded at $41.00 and the percentage gap between open changing to regular change was -0.02%. Enbridge Inc. (NYSE:ENB) and Spectra Energy Corp (SE) reported that previously reported merger of the two companies (the Transaction) has received all required regulatory clearances under the merger contract, including from the Canadian Competition Bureau, and is expected to close on February 27, 2017.
“We are very pleased to have now received all required regulatory clearances and we look forward to realizing the important consumer and shareholder benefits of combining these two strong companies,” said Al Monaco, President and Chief Executive Officer of Enbridge.
“With the completion of the Transaction, Enbridge will become a leading global energy infrastructure company and the largest in North America with roughly C$166 billion (US$126 billion) in enterprise value and the strongest liquids and natural gas infrastructure franchises on the continent. We will have a diverse set of low-risk businesses comprised of a best in class network of crude oil, liquids and natural gas pipelines, a large portfolio of strong, regulated gas distribution utilities and a growing renewable power generation platform.
The combined company will be positioned to provide integrated services and first and last mile connectivity to virtually all key liquids and gas supply basins and demand markets in North America.”
The firm’s current ratio calculated as 0.50 for the most recent quarter. The firm past twelve months price to sales ratio was 5.87 and price to cash ratio remained 61.67. As far as the returns are concern, the return on equity was recorded as 4.40% and return on investment was 6.00% while its return on asset stayed at 0.90%. The firm has total debt to equity ratio measured as 2.04.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -2.87% to $42.02. Integra LifeSciences Holdings Corp. (IART) on Thursday declared fourth-quarter net income of $28.2 million. The Plainsboro, New Jersey-based company said it had profit of 35 cents per share. Earnings, adjusted for one-time gains and costs, were 52 cents per share. The results matched Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was also for earnings of 52 cents per share.
The medical device maker posted revenue of $255.7 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $256.1 million. For the year, the company declared net income of $74.6 million, or 94 cents per share, swinging to a profit in the period. Revenue was declared as $992.1 million. Integra expects full-year earnings in the range of $1.88 to $1.94 per share. The share price of IART attracts active investors, as stock price of week volatility recorded 2.36%. The stock is going forward to its 52-week low with 47.18% and lagging behind from its 52-week high price with -8.39%.